Xtant Medical Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Xtant Medical Holdings (XTNT) Reports Q2 Loss of $0.54
August 9, 2017 5:32 PM EDTXtant Medical Holdings (NYSE: XTNT) reported Q2 EPS of ($0.54), versus ($0.37) reported last year. Revenue for the quarter came in at $21.4 million, versus $21.5 million reported last year.
For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.
... More